牡丹江医科大学学报

参考文献

[1] FYFE I.A clinically useful MRI marker of PD?[J].Nature Reviews Neurology,2019,15(1):2-3.

[2] 曾辉，刘莹.帕金森病诊断中MRI检查的应用价值研究[J].影像研究与医学应用，2019,3(19):144-145.

[3] SEPPI K,SCHOCKE M F H,DONNEMILLER E,et al.Comparison of diffusion-weighted imaging and IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease[J].Movement Disorders:Official Journal of the Movement Disorder Society,2004,19(12):1438-1445.

[4] 林瀚波，唐彬，薛冬圳，等.MR扩散加权成像对多系统萎缩、进行性核上性麻痹及帕金森病的鉴别诊断价值[J].海南医学，2020,31(21):2786-2789.

[5] ZHENG Z,SHEMMASSIAN S,WIJEKOON C,et al.DTI correlates of distinct cognitive impairments in Parkinson's disease[J].Human Brain Mapping,2014,35(4):1325-1333.

[6] LI W,LIU J,SKIDMORE F,et al.White matter microstructure changes in the thalamus in Parkinson disease with depression:A diffusion tensor MR imaging study[J].AJNR,2010,31(10):1861.

[7] 金芳，耿悦，陈菊萍，等.氢质子磁共振波谱成像在帕金森病早期诊断中的应用研究[J].交通医学，2020,34(4):416-419.

[8] 郑志娟，付文玉，王峻清，等.应用改良质子磁共振波谱技术研究帕金森病大鼠纹状体内神经代谢的变化[J].生物医学工程学杂志，2010,27(3):524-528

[9] 王贺，司景荣.磁共振波谱分析在早期帕金森病诊断及普拉克索疗效监测的应用[J].中国老年学杂志，2020,40(16):3475-3477.

[10] 陆健美，贾中正，马松华，等.“燕尾征”在原发性帕金森病患者中的诊断效果及临床治疗指导价值研究[J].当代医学，2020,26(32):1-3.

[11] 孙雪婷.磁敏感加权成像黑质“燕尾征”在帕金森病中的诊断价值[D].重庆医科大学，2020.

[12] 姚舜.基于磁敏感成像对抑郁症患者脑铁的研究[D].江苏大学，2018.

[13] LANGKAMMER C,SCHWESER F,KREBS N,et al.Quantitative susceptibility mapping(QSM)as a means to measure brain iron?A post mortem validation study[J].NeuroImage,2012,62(3):1593-1599.

[14] SJOSTROM H,GRANBERG T,WESTMAN E,et al.Quantitative susceptibility mapping differentiates between parkinsonian disorders[J].Parkinsonism Related Disorders,2017,44(8):51-57.

[15] 安荷娣，RAJEEV O,秧杰，等.磁共振定量磁化率成像定量帕金森病患者脑铁沉积的临床研究[J].中华神经科杂志，2016,49(4):299-301

[16] SASAKI M,ERI S,TOHYAMA K,et al.Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease[J].Neuroreport,2006,17(11):1215-1218.

[17] PRASAD S,STEZIN A,LENKA A,et al.Three-dimensional neuromelanin-sensitive magnetic resonance imaging of the substantia nigra in Parkinson's disease[J].European journal of neurology,2018,25(4):680-686.

[18] WANG J,LI Y,HUANG Z,et al.Neuromelanin-sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo Parkinson's disease and its phenotypes[J].European journal of neurology,2018,25(7):949-973.

[19] FABBRI M,REIMAO S,CARVALHO M,et al.Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease[J].J Parkinsons Dis,2017,7(3):491-501.

[20] CASTELLANOS G,FERNANDEZ-SEARA M A,LORENZO-BETANCOR O,et al.Automated neuromelanin imaging as a diagnostic biomarker for Parkinson's disease[J].Mov Disord,2015,30(7):945-952.